Delta sleep-inducing peptide and its tetrapeptide analogue alleviate severity of metaphit seizures

Olivera Stanojlović1, Dragana Zivanović, Slobodan Mirković

  • 1Department of Physiology, School of Medicine, University of Belgrade, Visegradska 26/II, 11000, Serbia, Belgrade, Yugoslavia. maxol@eunet.yu

Insights

Delta sleep-inducing peptide (DSIP) and its analogue DSIP(1-4) show promise as antiepileptics. These compounds reduced the severity and incidence of metaphit-induced audiogenic seizures in rats.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Audiogenic seizures are a model for studying epilepsy.
  • Metaphit is a known inducer of audiogenic seizures.
  • Delta sleep-inducing peptide (DSIP) is a naturally occurring peptide with potential neuromodulatory effects.

Purpose of the Study:

  • To investigate the anticonvulsant effects of DSIP and its analogue DSIP(1-4) on metaphit-induced audiogenic seizures.
  • To evaluate the impact of DSIP and DSIP(1-4) on electroencephalogram (EEG) power spectra, particularly delta waves.

Main Methods:

  • Adult male Wistar rats were divided into five groups: saline, metaphit, DSIP, metaphit+DSIP, and metaphit+DSIP(1-4).
  • Audiogenic seizures were induced using an electric bell (100+/-3 dB, 5-8 kHz).
  • EEG recordings and power spectral analysis were performed after skull implantation of electrodes.

Main Results:

  • Metaphit administration led to polyspike and spike-wave complex patterns in EEG and increased power spectra for 30 hours.
  • The incidence and severity of metaphit-induced seizures peaked 7-12 hours post-injection.
  • Both DSIP and DSIP(1-4) significantly increased delta wave power spectra and reduced seizure incidence, severity, and the tonic component of convulsions.

Conclusions:

  • DSIP and its analogue DSIP(1-4) exhibit significant anticonvulsant properties against metaphit-induced audiogenic seizures.
  • These findings suggest that DSIP and DSIP(1-4) hold potential as novel antiepileptic agents.

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...